• HC Wainwright Reaffirms Buy Rating for Cytokinetics (NASDAQ:CYTK)

    Source: Buzz FX / 01 Mar 2025 08:32:14   America/New_York


    HC Wainwright Reaffirms Buy Rating for Cytokinetics (NASDAQ:CYTK) Written by MarketBeat March 1, 2025 Share Link copied to clipboard. Cytokinetics ( NASDAQ:CYTK - Get Free Report ) 's stock had its "buy" rating reiterated by equities resear
    Read more...
Share on,